NCT03048981

Brief Summary

Many patients undergoing surgery use naturopathic drugs, including fish oil. Fish oil has been reported to increase bleeding in patients through inhibiting platelet aggregation and prolonging of clot formation time. The Swedish Medical Products Agency recommends that patients stop taking the naturopathic medicines including fish oil two weeks prior planed surgery. The aim of this study is to examine the effects of fish oil given to healthy volunteers using point of care coagulation assessment and flow dependent Cellix instrument before and after intake of fish oil.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 9, 2017

Completed
20 days until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2017

Completed
Last Updated

May 9, 2017

Status Verified

May 1, 2017

Enrollment Period

2 months

First QC Date

February 2, 2017

Last Update Submit

May 5, 2017

Conditions

Keywords

Thrombocyte aggregationFish oilAlternative medicinePoint of care testingCoagulation monitoring

Outcome Measures

Primary Outcomes (2)

  • Thrombocyte aggregation measured with multiple electrode aggregometry

    Multiple electrode aggregometry gives a area under the curve proportional to thrombocyte aggregation

    Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline

  • Thrombocyte aggregation measured with Cellix's microfluidic pumps and biochips

    Cellix's microfluidic pumps and biochips gives an thrombosis area proportional to thrombocyte aggregation

    Change of thrombocyte aggregation directly after intake period of 7 days compared to baseline

Secondary Outcomes (2)

  • Coagulation measured with the viscohemostatic instrument ROTEM

    Change of coagulation directly after intake period of 7 days compared to baseline

  • Coagulation measured with the viscohemostatic instrument and Sonoclot

    Change of coagulation directly after intake period of 7 days compared to baseline

Study Arms (1)

Fish oil intake

EXPERIMENTAL

Healthy volunteers given maximum dose of fish oil for 10 days.

Drug: Fish oil

Interventions

Blood samples before and after 10 day intake of maximum dose fish oil

Fish oil intake

Eligibility Criteria

Age19 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non smoking healthy volunteers with written consent to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensive and perioperative care. Skåne University Hospital. Lund

Lund, Skåne County, 22185, Sweden

Location

Related Publications (1)

  • Bagge A, Schott U, Kander T. Effects of naturopathic medicines on Multiplate and ROTEM: a prospective experimental pilot study in healthy volunteers. BMC Complement Altern Med. 2016 Feb 17;16:64. doi: 10.1186/s12906-016-1051-y.

MeSH Terms

Conditions

Platelet Aggregation, SpontaneousAtherosclerosis

Interventions

Fish Oils

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

OilsLipids

Study Officials

  • Thomas Kander, MD, Phd

    Dept. of Clinical Sciences, Lund University, SWEDEN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Before and after
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 9, 2017

Study Start

March 1, 2017

Primary Completion

May 2, 2017

Study Completion

May 2, 2017

Last Updated

May 9, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will share

IPD will be available upon reasonable request

Locations